BIOCARTIS

In News

Press Release Biocartis NV: Biocartis Announces Agreement with City of Hope to Explore Development of Rapid Gene Signature Test for Early Detection of Pancreatic Cancer - GlobeNewswire

GlobeNewswire - Jun 09, 2026

Biocartis Earns European Certification for Colorectal Cancer Companion Diagnostic Test - Clinical Lab Products

Clinical Lab Products - Apr 17, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic - Pharmafile

Pharmafile - Jan 14, 2026

FDA approves Biocartis Idylla Cdx MSI colorectal cancer test - bioworld.com

bioworld.com - Sep 16, 2025

Press Release Biocartis NV: Biocartis and Discovery Life - GlobeNewswire

GlobeNewswire - Jul 07, 2026

FDA Grants Premarket Approval to Idylla CDx MSI Test for MSI-H CRC - OncLive

OncLive - Sep 15, 2025

Biocartis Introduces Influenza-Respiratory Virus Panel on Idylla Platform - respiratory-therapy.com

respiratory-therapy.com - Nov 09, 2023

DC Advisory advises Biocartis on enforcement by secured creditors and recapitalization of its main operating subsidiaries - dcadvisory.com

dcadvisory.com - Nov 16, 2023

Biocartis Launches qPCR POLE/POLD1 Mutational Assay - Oncology Nursing News

Oncology Nursing News - Apr 04, 2025

Press Release Biocartis NV: Biocartis to collaborate with Mayo Clinic on breast cancer gene signatures - GlobeNewswire

GlobeNewswire - Jan 12, 2026

Biocartis grabs lab space, staff from Johnson & Johnson to fuel U.S. expansion - Fierce Biotech

Fierce Biotech - Mar 02, 2018

Biocartis, MRC Technology to Develop Liquid Biopsy Test for Breast Cancer - Inside Precision Medicine

Inside Precision Medicine - Jun 07, 2017

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment